Zhu Ying, Fu Lei, Jing Wang, Guo Dong, Chen Yan, Kong Li, Yu Jinming
Weifang Medical University, Weifang, Shandong Province, China.
Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong Province, China.
Asia Pac J Clin Oncol. 2019 Jun;15(3):101-107. doi: 10.1111/ajco.13112. Epub 2019 Jan 4.
Currently, the use of magnetic resonance imaging (MRI) in patients with esophageal carcinoma is limited. However, the quality of MRI for esophageal carcinoma continues to improve and the importance of MRI in patients with esophageal carcinoma has been gradually recognized. Compared with endoscopic ultrasound and computed tomography applied in T and N staging, MRI has now achieved excellent results after the imaging technique has been optimized. We review the literature on MRI and discuss the future of MRI in esophageal carcinoma. While the role of MRI in staging, tumor volume target delineation and evaluation for preoperative chemoradiotherapy, prognosis and recurrence is still evolving. The application of MRI in esophageal carcinoma has a bright future and potential to improve precision of T and N staging as well as treatment delivery.
目前,磁共振成像(MRI)在食管癌患者中的应用有限。然而,用于食管癌的MRI质量不断提高,其在食管癌患者中的重要性已逐渐得到认可。与应用于T和N分期的内镜超声及计算机断层扫描相比,在成像技术优化后,MRI现已取得了优异的结果。我们回顾了关于MRI的文献,并讨论了MRI在食管癌中的未来发展。虽然MRI在分期、肿瘤体积靶区勾画以及术前放化疗评估、预后和复发方面的作用仍在不断发展。MRI在食管癌中的应用前景光明,具有提高T和N分期精度以及治疗准确性的潜力。